$DFTX
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Healthcare
Sector
Biotechnology
Industry
Robert Barrow
CEO
74
Employees
$18.94
Current Price
$1.64B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 3 | $796,998.97 | 43,151 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 3 | $796,998.97 | 43,151 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 3 | $796,998.97 | 43,151 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 3 | $796,998.97 | 43,151 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 3 | $796,998.97 | 43,151 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Karlin Daniel Chief Medical Officer | Sale | 8,018 | $18.47 | $148,092.46 | View Details |
| Mar 25, 2026 | Sullivan Mark Chief Legal Officer | Sale | 10,702 | $18.47 | $197,665.94 | View Details |
| Mar 25, 2026 | Barrow Robert Director | Sale | 24,431 | $18.47 | $451,240.57 | View Details |
9 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.45
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history